CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Open platformOpen platform

Caris Life Sciences to present CapeAI study predicting capecitabine response in ER+ breast cancer at ESMO 2026

By Public Technologies
  • Caris Life Sciences flagged eight AI-driven precision-oncology studies slated for presentation at the ESMO Congress 2026 in Madrid.
  • Results have not yet been presented; posters are scheduled for Oct. 23–27, 2026, with Caris-led sessions on Oct. 25.
  • Two Caris-led studies aim to improve breast-cancer treatment selection by predicting capecitabine response, risk, and endocrine-therapy benefit stratification.
  • Collaborative posters extend the approach to lung cancer, endometrial cancer, melanoma, and immuno-oncology to support biomarker discovery and therapy-response prediction.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Caris Life Sciences Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610140830PR_NEWS_USPR_____DA71516) on October 14, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk